In-Depth Industry Editions
The In-Depth Industry Editions are the standards behind the products - long-form, numbered briefings that take one bioprocess topic at a time and set out what "good" should mean, attribute by attribute, proven on the Certificate of Analysis.
Each edition is a free, ungated web page with an optional PDF. They are the deep companion to our shorter technical papers: where a tech paper makes a point, an edition sets a standard.
One standard per topic
Eight editions are live: two foundation editions (downstream and water), one per application - antibodies, cell & gene therapy, mRNA, vaccines and liposomes & LNP - and C05 The Open Path, the staged route from bench to filing. Read each one online or download the PDF to share.
Edition D01
Standardising the Downstream
One qualified GMP toolkit built from a small set of recurring stock solutions - research grade to GMP, with the process-specific tail covered by custom manufacture.
Edition D02
The WFI Beyond Standard
Why "meets WFI" is only a floor - the beyond-compendial water standard, with all 24 ICH Q3D elemental impurities specified and measured, and the two metals that oxidise an antibody (copper and iron) controlled at the source. FDA Type IV (excipient) DMF filed: MF044505.
Edition A02
Standardising the Antibody Program
The 13-step monoclonal-antibody program - five upstream, seven downstream and a QC & stability step - delivered as ready-to-use process bundles, one labelled box per step.
Edition A03
One Foundation for Cell & Gene Therapy
One serum-free, xeno-free toolkit for the whole cell & gene therapy process - a shared upstream, then the cell-therapy, viral-vector and plasmid-DNA tracks, research to GMP. Built on nuclease-free, ultra-low-endotoxin WFI Beyond.
Edition A04
One Foundation for the Whole mRNA Process
One qualified GMP supply base for the cell-free mRNA process - nuclease-free water and IVT buffers through RNA purification and LNP encapsulation to excipient-grade formulation. Built on WFI Beyond.
Edition A05
One Foundation for the Whole Vaccine Process
One GMP supply base for the whole vaccine process - cell-line-specific viral culture media (Vero, MDCK, BHK21, Sf9, S2), host-cell DNA clearance, purification and excipient-grade formulation.
Edition A06
One Foundation for the Whole Liposome Process
One qualified GMP supply base for a lipid-based process - from the aqueous phase and hydration buffers, through formation, size reduction, purification and solvent removal, to excipient-grade formulation. Built on WFI Beyond.
Edition C05
The Open Path
One qualified GMP foundation taken up in three opt-in stages - on-stock GMP buffers and media (speed), the WFI Beyond water upgrade (safety), DMF and stability support (formalities) - from the research bench to the regulatory filing, without changing the chemistry.
All editions in one table
| Edition | Topic | Title | Format |
|---|---|---|---|
| D01 | Downstream | Standardising the Downstream | Web page + PDF (Rev 1.3) |
| D02 | Water | The WFI Beyond Standard | Web page + PDF (Rev 2.3) |
| A02 | Monoclonal antibodies | Standardising the Antibody Program | Web page + PDF (Rev 2.0) |
| A03 | Cell & gene therapy | One Foundation for Cell & Gene Therapy | Web page + PDF (Rev 1.0) |
| A04 | mRNA | One Foundation for the Whole mRNA Process | Web page + PDF (Rev 1.0) |
| A05 | Vaccines | One Foundation for the Whole Vaccine Process | Web page + PDF (Rev 1.0) |
| A06 | Liposomes & LNP | One Foundation for the Whole Liposome Process | Web page + PDF (Rev 1.0) |
| C05 | Custom Solutions | The Open Path | Web page (PDF to follow) |
The companion technical papers
Eight shorter papers, each making one argument in focus - free and ungated, with an optional PDF.
Technical paper TP-01
The Open Downstream
The commercial case for one qualified, on-stock GMP downstream - a GMP product for every DSP step, qualified once and scaled without re-qualification.
Technical paper TP-02
Beyond Compendial - Applied to Buffers and Reagents
The modern ICH impurity dossier - elemental impurities, residual solvents, nitrosamines, extractables & leachables, TSE/BSE - mapped to buffers and reagents and to each modality.
Technical paper TP-03
From Bench to GMP - Organizing and Scaling Your Buffer Supply
When to stop making buffers in-house, the five hidden costs of staying there, and how to organise the transition to a qualified GMP supplier.
Technical paper TP-04
WFI Beyond - Beyond Compendial
Water for Injection beyond the monograph - endotoxin more than 50x and TOC 10x below the limit, all 24 ICH Q3D elements measured, backed by a filed FDA Type IV (excipient) DMF.
Technical paper TP-05
The Water in the Powder
A ready-to-use medium is ~99% water, so its impurity load is the powder's plus the reconstitution water's - the half almost nobody measures. Why the water belongs in the impurity budget.
Technical paper TP-06
Choosing a Viral-Inactivation Detergent
Four requirements - performance, compliant supply under REACH, animal origin and per-lot documentation - turned into a checklist, and the two PANclear grades for research and for GMP production.
Technical paper TP-07
Switching off the REACH Trap
A practical guideline for moving viral inactivation off octylphenol ethoxylates subject to REACH authorisation - six steps, a checklist and a 100 ml to 1000 L scale path.
Technical paper TP-08
WFI Beyond - Elemental-Impurity Stability
All 24 ICH Q3D elements still below limit at the 18-month stability point, in PET and PETG, 500 mL and 1000 mL - metal control that lasts, not just a release snapshot.
Three kinds of reading, one hub
Choose the depth you need - from proof in practice to a full standard.
About the In-Depth Industry Editions
What is an In-Depth Industry Edition?
How is an edition different from a technical paper?
Are they free, and do I have to register?
Build on the standard
Request a specification, a Certificate of Analysis, a WFI Beyond spec or a custom GMP quote - for antibody, mRNA, cell & gene, vaccine or liposome processes.
Or write to info@pan-celltech.com
PAN-Biotech GmbH · PAN-Celltech GmbH (GMP arm / manufacturer of record). WFI Beyond is opt-in, for further processing / as an excipient. GMP-compliant, audit-proven; EU Annex 1 is a capability, not a certification.